SRT3 on XETR. BUY.The uptrend is strong, price is close to some Supply but it is not fresh and not quite there yet. This is a great Demand level. Can consider holding it through the high at 371 as well.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.0 EUR
205.20 M EUR
3.40 B EUR
1.49 M
About SARTORIUS AG
Sector
CEO
Joachim Kreuzburg
Headquarters
Goettingen
Website
Founded
1990
ISIN
DE0007165607
FIGI
BBG01K3WRXS8
Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through following divisions: Bioprocess Solutions (BPS), and Lab Products and Service (LPS). The Bioprocess Solutions division focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The Lab Products and services division serves the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.
Sartorius: Target 180 Euro?After subsequent negative news, we see again a important floor broken and a falling knife movement. There are two different patterns indicating a move towards 180 or into a side movement corridor between 168 and 196 which is again 15 to 30% downwards potential. It's an ABC pattern (not a perfect on
Sartorius AG LONG Signal createdLooking on this weekly chart:
Price broke the triangle pattern to the upside
Price is over all moving averages
Looking at the last 10 years: Sartorius has a bullish seasonality until summer
Good trades, folks!
Short-term profit targetOn Friday TecDax favorite Sartorius AG underwent a fail breakout. So I will follow the short consolidation up to the FIB level representing the lower line of the symmetrical triangle. I assume that strong resistance may likely hold a third time, so that risk for loss is acceptable.
To cover the tra
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1SRT is 174.0 EUR — it has decreased by −1.81% in the past 24 hours. Watch SARTORIUS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange SARTORIUS stocks are traded under the ticker 1SRT.
1SRT stock has fallen by −5.74% compared to the previous week, the month change is a 1.52% rise, over the last year SARTORIUS has showed a −36.15% decrease.
We've gathered analysts' opinions on SARTORIUS future price: according to them, 1SRT price has a max estimate of 265.00 EUR and a min estimate of 212.00 EUR. Watch 1SRT chart and read a more detailed SARTORIUS stock forecast: see what analysts think of SARTORIUS and suggest that you do with its stocks.
1SRT reached its all-time high on Mar 22, 2024 with the price of 288.0 EUR, and its all-time low was 167.5 EUR and was reached on Nov 21, 2024. View more price dynamics on 1SRT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1SRT stock is 1.84% volatile and has beta coefficient of 1.50. Track SARTORIUS stock price on the chart and check out the list of the most volatile stocks — is SARTORIUS there?
Today SARTORIUS has the market capitalization of 12.18 B, it has decreased by −5.71% over the last week.
Yes, you can track SARTORIUS financials in yearly and quarterly reports right on TradingView.
SARTORIUS is going to release the next earnings report on Jan 23, 2025. Keep track of upcoming events with our Earnings Calendar.
1SRT earnings for the last quarter are 0.21 EUR per share, whereas the estimation was 0.86 EUR resulting in a −75.55% surprise. The estimated earnings for the next quarter are 1.07 EUR per share. See more details about SARTORIUS earnings.
SARTORIUS revenue for the last quarter amounts to 793.60 M EUR, despite the estimated figure of 814.79 M EUR. In the next quarter, revenue is expected to reach 867.25 M EUR.
1SRT net income for the last quarter is 14.20 M EUR, while the quarter before that showed 23.90 M EUR of net income which accounts for −40.59% change. Track more SARTORIUS financial stats to get the full picture.
Yes, 1SRT dividends are paid annually. The last dividend per share was 0.73 EUR. As of today, Dividend Yield (TTM)% is 0.41%. Tracking SARTORIUS dividends might help you take more informed decisions.
SARTORIUS dividend yield was 0.28% in 2023, and payout ratio reached 24.67%. The year before the numbers were 0.43% and 14.53% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has 14.61 K employees. See our rating of the largest employees — is SARTORIUS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SARTORIUS EBITDA is 871.90 M EUR, and current EBITDA margin is 26.12%. See more stats in SARTORIUS financial statements.
Like other stocks, 1SRT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SARTORIUS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SARTORIUS technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SARTORIUS stock shows the strong sell signal. See more of SARTORIUS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.